JS
AGN

Jeffrey Smith’s Allergan plc AGN Stock Holding History

Jeffrey Smith’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-11,700
Closed -$3.18M – 33
2015
Q3 		$3.18M Buy
11,700
+5,200
+80% +$1.6M 0.07% 28
2015
Q2 		$1.97M Buy
+6,500
New +$1.94M 0.04% 36

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Jeffrey Smith's AGN Position: Q4 2015 in Review

Jeffrey Smith sold out of Allergan plc (AGN) in Q4 2015, closing a stake of 11,700 shares — an estimated $3.18M sold.

Jeffrey Smith first reported a position in AGN in Q2 2015 and held it in 2 quarters. The position peaked at $3.18M in Q3 2015. 1,110 funds tracked by Wall St. Rank hold AGN as of Q4 2015.

  • Jeffrey Smith reported no remaining Allergan plc position as of Q4 2015 after selling out during the quarter.
  • Jeffrey Smith sold 11,700 Allergan plc shares in Q4 2015, an estimated $3.18M.
  • Jeffrey Smith first reported a position in Allergan plc in Q2 2015 and held it in 2 quarters.
  • Jeffrey Smith's Allergan plc position peaked at $3.18M in Q3 2015.
  • 1,110 funds tracked by Wall St. Rank held Allergan plc as of Q4 2015.

Based on Starboard Value's 13F filing for Q4 2015, filed 12 Feb 2016.